WEDNESDAY, Jan. 5, 2022 (HealthDay News) Millions of people are at increased risk of type 2 diabetes and high blood pressure and don t even know it, due to a
WEDNESDAY, Jan. 5, 2022 (HealthDay News) Millions of people are at increased risk of type 2 diabetes and high blood pressure and don t even know it, due to a
AUA 2021 Phase 3 HERO Study, gonadotropin-releasing hormone (GnRH) agonists and antagonists, Relugolix vs Leuprolide, safety and efficacy of relugolix in men with advanced prostate cancer.
Science’s COVID-19 reporting is supported by the Heising-Simons Foundation.
After the first surge of COVID-19 cases in spring 2020, a new worry emerged: Some people didn’t get better. For those with so-called Long COVID, lingering symptoms ranged from brain fog and intense fatigue to shortness of breath and loss of smell and taste. So far, there’s little clarity about what causes or how to treat this constellation of symptoms. Some surveys suggest between 10% and 30% of people infected with the pandemic coronavirus may struggle to recover, but these data are preliminary.
Emilia Liana Falcone, an infectious disease specialist at the Montreal Clinical Research Institute, and Michael Sneller, an infectious disease specialist at the National Institute of Allergy and Infectious Diseases (NIAID), are each leading a large Long COVID clinical trial. They are recruiting volunteers who’ve had COVID-19 some with ongoing symptoms and some without along with a control group of people wh